Singleron and Bioscreen Announce Strategic Partnership to Enhance Access to Single Cell Multi-Omics Solutions for India Researchers 08.10.20243’Cologne, October 8, 2024 – Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India. Under this agreement, Bioscreen will become the exclusive distributor of Singleron’s cutting-edge single cell multi-omics solutions in the Indian market.Bioscreen will distribute Singleron’s comprehensive suite of single cell multi-omics solutions, which covers the entire single cell analysis workflow, including tissue dissociation, library preparation, and bioinformatics analysis. The comprehensive support provides a smooth experience for researchers regardless of their prior experience in single cell analysis.“We are thrilled to partner with Singleron to introduce their advanced single cell multi-omics solutions to the Indian market,” Prabhakar S, Director – Sales & Marketing of Biocreen Instruments Pvt. Ltd. “India presents immense potential for single cell analysis, yet researchers often encounter challenges such as limited access to equipment, high costs, and a shortage of experienced teams. This collaboration allows us to provide researchers with Singleron’s comprehensive end-to-end workflow, enabling deeper insights into cellular biology and accelerating breakthroughs in biomedical research.”The collaboration highlights the growing demand in the Asia-Pacific (APAC) region for innovative single cell analysis solutions. As the life sciences sector in India continues to advance, the need for precise and comprehensive tools to analyze cellular heterogeneity is becoming increasingly critical.Singleron shares this enthusiasm. “We are excited to work with Bioscreen as our exclusive distributor in India,” said Jonathan Scolnick, General Manager, Singleron Biotechnologies APAC. “Bioscreen’s extensive network and expertise in the life sciences sector make them the ideal partner to expand our presence in this growing life sciences and clinical research market. Together, we aim to empower researchers with the tools they need to unlock the complexities of single cell biology.”About Singleron BiotechnologiesSingleron Biotechnologies advances precision medicine and human health through pioneering single cell multi-omics solutions. Its current product portfolio includes high throughput instruments for automated single cell processing and tissue dissociation, reagents, bioinformatics software, and a comprehensive single cell knowledgebase.Founded in 2018, Singleron operates globally with offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in more than 3,000 laboratories in hospitals, research institutes, and pharmaceutical companies.About BioscreenWe, Biocreen Instruments Pvt. Ltd. is a leading provider in the bioresearch industry, established in 2005 with a mission to deliver superior quality products and services. Our company has experienced consistent growth by leveraging cutting-edge technologies and innovative solutions. Our company is dedicated to embracing new technologies and innovations to meet the evolving needs of the bioresearch sector. This proactive approach allows them to stay at the forefront of industry trends.We provide a wide range of off-the-shelf solutions tailored to various technological needs within the bioresearch industry, ensuring that customers receive the best tools for their specific requirements. Through collaborations with world-renowned companies, Bioscreen has strengthened its position in the market, enhancing its ability to offer advanced solutions and stay ahead in the industry. Bioscreen Instruments Pvt. Ltd. continues to be a significant player in the bioresearch field, committed to advancing scientific research and supporting researchers with top-quality products and exceptional service. https://www.bioscreen.inCheck out our latest news and events Learn more 24.11.20 Singleron Partners with TOMY to Expand Single Cell Offerings in Japan Cologne, November 20, 2024 – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co.,… Read more 24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more 24.09.11 Singleron Launches New All-in-One sCelLiVE® Tissue Dissociation Kit for Skin Cologne, 11th September 2024 – Singleron announced the launch of sCelLiVE® Tissue Dissociation Kit (Skin) (sCelLiVE Skin), a new all-in-one solution for human and mouse skin tissue…. Read more
24.11.20 Singleron Partners with TOMY to Expand Single Cell Offerings in Japan Cologne, November 20, 2024 – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co.,… Read more
24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more
24.09.11 Singleron Launches New All-in-One sCelLiVE® Tissue Dissociation Kit for Skin Cologne, 11th September 2024 – Singleron announced the launch of sCelLiVE® Tissue Dissociation Kit (Skin) (sCelLiVE Skin), a new all-in-one solution for human and mouse skin tissue…. Read more